Antimicrobial Stewardship: Fighting Antimicrobial Resistance and Protecting Global Public Health
- PMID: 33402841
- PMCID: PMC7778387
- DOI: 10.2147/IDR.S290835
Antimicrobial Stewardship: Fighting Antimicrobial Resistance and Protecting Global Public Health
Abstract
Antimicrobial resistance (AMR) is a serious threat to global public health. It increases morbidity and mortality, and is associated with high economic costs due to its health care burden. Infections with multidrug-resistant (MDR) bacteria also have substantial implications on clinical and economic outcomes. Moreover, increased indiscriminate use of antibiotics during the COVID-19 pandemic will heighten bacterial resistance and ultimately lead to more deaths. This review highlights AMR's scale and consequences, the importance, and implications of an antimicrobial stewardship program (ASP) to fight resistance and protect global health. Antimicrobial stewardship (AMS), an organizational or system-wide health-care strategy, is designed to promote, improve, monitor, and evaluate the rational use of antimicrobials to preserve their future effectiveness, along with the promotion and protection of public health. ASP has been very successful in promoting antimicrobials' appropriate use by implementing evidence-based interventions. The "One Health" approach, a holistic and multisectoral approach, is also needed to address AMR's rising threat. AMS practices, principles, and interventions are critical steps towards containing and mitigating AMR. Evidence-based policies must guide the "One Health" approach, vaccination protocols, health professionals' education, and the public's awareness about AMR.
Keywords: One Health; antibiotics; antimicrobial resistance; antimicrobial stewardship program; global health; multidrug-resistant.
© 2020 Majumder et al.
Conflict of interest statement
Dr. Md Anwarul Azim Majumder is the Editor-in-Chief of Advances in Medical Education and Practice with Dove Medical Press. All authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
Figures
References
-
- World Health Organization. Record number of countries contribute data revealing disturbing rates of antimicrobial resistance; 2020. Available from: https://www.who.int/news-room/detail/01-06-2020-record-number-of-countri.... Accessed December9, 2020.
-
- World Health Organization. 2020 Antibiotic resistance; 2020. Available from: https://www.who.int/news-room/fact-sheets/detail/antibiotic-resistance. Accessed December9, 2020.
-
- Centers for Disease Control and Prevention. Antibiotic/Antimicrobial Resistance (AR/AMR); 2020. https://www.cdc.gov/drugresistance/index.html. Accessed December9, 2020.
-
- World Medical Association (WMA). WMA statement on antimicrobial resistance. Available from: https://www.wma.net/policies-post/wma-statement-on-resistance-to-antimic.... Accessed December9, 2020.
-
- World Health Organization. Turning Plans into Action for Antimicrobial Resistance (AMR). Working Paper 2.0: Implementation and Coordination. Geneva: World Health Organization; 2019.
Publication types
LinkOut - more resources
Full Text Sources